Submit Manuscripts
Author Information
Subscribe/Renew
Email Alerts
Feedback
RSS Feed

About the Journal
Editorial Board & Staff

Interventions Homepage Imaging Homepage Interventions Homepage Imaging Homepage

ACC.org
Cardiosmart
Cardiosource
CVN
Imaging Library
JACC Imaging
JACC Interventions

ACC/AHA 2008 Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2007; 49:2350-2355, doi:10.1016/j.jacc.2007.02.054 (Published online 1 June 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Conen, D.
Right arrow Articles by Osswald, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Conen, D.
Right arrow Articles by Osswald, S.

Amiodarone-Induced Thyrotoxicosis

Clinical Course and Predictors of Outcome

David Conen, MD*, Ludovic Melly*, Christoph Kaufmann, MD*, Stefan Bilz, MD{dagger}, Peter Ammann, MD*, Beat Schaer, MD*, Christian Sticherling, MD*, Beat Muller, MD{dagger} and Stefan Osswald, MD, FACC, FESC*,*

* Department of Cardiology, University Hospital, Basel, Switzerland
{dagger} Department of Endocrinology, Diabetes, and Clinical Nutrition, University Hospital, Basel, Switzerland.


Figure 1
View larger version (10K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 1 Event-Free Survival

Kaplan-Meier event-free survival for patients with normal versus abnormal left ventricular function (A) and for patients treated with versus without prednisone (B). Normal ejection fraction (EF) was defined as EF ≥50% by echocardiography (or described as normal in 7 patients). For patients with long follow-up, follow-up time is censored at 60 months.

 
 
  cardiology careers collections past issues search home